2024
Ex Vivo Immunization: A Strategy for Immunization Against SARS-CoV-2
Singh H, Nuthalapati P, Yendapalli P, Sahu D. Ex Vivo Immunization: A Strategy for Immunization Against SARS-CoV-2. 2024, 258-271. DOI: 10.1039/bk9781837672813-00258.Peer-Reviewed Original ResearchPeripheral blood mononuclear cellsNatural killer cellsCell-mediated immunityBlood mononuclear cellsEnhanced immune responseNaive lymphocytesDendritic cellsKiller cellsT cellsAntigen presentationB cellsMononuclear cellsImmune responseSARS-nCoV-2Human hostSignaling cascadesSARS-CoV-2Global pandemic coronavirus diseaseVirion particlesImmunityMass immunizationAdverse effectsCoronavirus 2Pandemic coronavirus disease
2022
Role of CD4+ T Cells in Parkinson's Disease
Ghanta M, Nuthalapati P, Merchant N, Chenchula S, Hussain F, Ak A, Bhaskar L. Role of CD4+ T Cells in Parkinson's Disease. Critical Reviews In Immunology 2022, 42: 17-25. PMID: 37082948, DOI: 10.1615/critrevimmunol.2023047372.Peer-Reviewed Original ResearchConceptsCD4+ T cellsT cellsExpression of CD4+ T cellsCD4+ T cell phenotypePeripheral adaptive immunityT-cell phenotypeNervous systemMulti-system disorderDopaminergic neuronal lossCentral nervous systemTreatment of PDImmune dysfunctionSymptomatic treatmentAdaptive immunityCD4Disease pathogenesisNeuronal lossProgressive conditionAnti-inflammatoryDiseaseParkinson's diseaseTreatmentPhenotypeFunctional profiles